KATIE LYVER: Open Payments
NPI 1336922327 · BAY SHORE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,404 in 111 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $2,810 · 2025 $2,404
Food & beverage: $2,292Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 30 | $504 |
| Teva Pharmaceuticals USA, Inc. | 14 | $334 |
| Alkermes, Inc. | 13 | $285 |
| E.R. Squibb & Sons, L.L.C. | 13 | $224 |
| Axsome Therapeutics, Inc. | 5 | $215 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $185 |
| Otsuka America Pharmaceutical, Inc. | 7 | $155 |
| Vanda Pharmaceuticals Inc. | 9 | $145 |
| ABBVIE INC. | 5 | $129 |
| Lundbeck LLC | 5 | $120 |
Products named: INGREZZA, ARISTADA, COBENFY, Auvelity, CAPLYTA, UZEDY, REXULTI, VRAYLAR.
Industry payments across NY — which companies pay providers there.
